Will China’s Retaliatory Tariffs Galvanize Manufacturing Onshoring?
Some Firms Are Already Localizing
China’s imposed large retaliatory tariffs on US pharmaceuticals on 10 April, but some domestic firms with in-licensed, US-origin assets were already moving to localized manufacturing.
